rs139691746

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002547.3(OPHN1):​c.2056C>T​(p.Pro686Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000341 in 1,206,509 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 108 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0019 ( 0 hom., 56 hem., cov: 22)
Exomes 𝑓: 0.00019 ( 0 hom. 52 hem. )

Consequence

OPHN1
NM_002547.3 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.125
Variant links:
Genes affected
OPHN1 (HGNC:8148): (oligophrenin 1) This gene encodes a Rho-GTPase-activating protein that promotes GTP hydrolysis of Rho subfamily members. Rho proteins are important mediators of intracellular signal transduction, which affects cell migration and cell morphogenesis. Mutations in this gene are responsible for OPHN1-related X-linked cognitive disability with cerebellar hypoplasia and distinctive facial dysmorhphism. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0058640838).
BP6
Variant X-68063956-G-A is Benign according to our data. Variant chrX-68063956-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 195589.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-68063956-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00189 (208/110193) while in subpopulation AFR AF= 0.00631 (191/30253). AF 95% confidence interval is 0.00558. There are 0 homozygotes in gnomad4. There are 56 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 56 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OPHN1NM_002547.3 linkc.2056C>T p.Pro686Ser missense_variant Exon 21 of 25 ENST00000355520.6 NP_002538.1 O60890-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OPHN1ENST00000355520.6 linkc.2056C>T p.Pro686Ser missense_variant Exon 21 of 25 1 NM_002547.3 ENSP00000347710.5 O60890-1

Frequencies

GnomAD3 genomes
AF:
0.00189
AC:
208
AN:
110141
Hom.:
0
Cov.:
22
AF XY:
0.00173
AC XY:
56
AN XY:
32353
show subpopulations
Gnomad AFR
AF:
0.00633
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000865
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000289
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00474
GnomAD3 exomes
AF:
0.000501
AC:
90
AN:
179770
Hom.:
0
AF XY:
0.000279
AC XY:
18
AN XY:
64480
show subpopulations
Gnomad AFR exome
AF:
0.00603
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000185
AC:
203
AN:
1096316
Hom.:
0
Cov.:
31
AF XY:
0.000144
AC XY:
52
AN XY:
361794
show subpopulations
Gnomad4 AFR exome
AF:
0.00603
Gnomad4 AMR exome
AF:
0.000683
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000119
Gnomad4 OTH exome
AF:
0.000413
GnomAD4 genome
AF:
0.00189
AC:
208
AN:
110193
Hom.:
0
Cov.:
22
AF XY:
0.00173
AC XY:
56
AN XY:
32415
show subpopulations
Gnomad4 AFR
AF:
0.00631
Gnomad4 AMR
AF:
0.000864
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000290
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00468
Alfa
AF:
0.000243
Hom.:
10
Bravo
AF:
0.00244
ESP6500AA
AF:
0.00860
AC:
33
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000461
AC:
56

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Nov 21, 2018
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

not specified Benign:3
Nov 13, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 13, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jul 24, 2015
Genetic Services Laboratory, University of Chicago
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
Jun 22, 2017
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

X-linked intellectual disability-cerebellar hypoplasia syndrome Benign:1
Sep 22, 2021
Fulgent Genetics, Fulgent Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.88
T
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.3
DANN
Benign
0.20
DEOGEN2
Benign
0.041
T
FATHMM_MKL
Benign
0.023
N
LIST_S2
Benign
0.62
T
M_CAP
Benign
0.0022
T
MetaRNN
Benign
0.0059
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.26
N
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.89
N
REVEL
Benign
0.090
Sift
Benign
0.32
T
Sift4G
Benign
0.20
T
Polyphen
0.0
B
Vest4
0.041
MVP
0.18
MPC
0.12
ClinPred
0.0052
T
GERP RS
-1.2
Varity_R
0.038
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139691746; hg19: chrX-67283798; API